CC BY-NC-ND 4.0 · Endosc Int Open 2018; 06(09): E1093-E1099
DOI: 10.1055/a-0581-9005
Original article
Owner and Copyright © Georg Thieme Verlag KG 2018

Endoscopic treatment of esophageal fistulas after esophagectomy with injection of an alpha-cyanoacrylate monomer: a phase II study

Toshiyasu Ojima
Second Department of Surgery, Wakayama Medical University, Wakayama, Japan
,
Masaki Nakamura
Second Department of Surgery, Wakayama Medical University, Wakayama, Japan
,
Mikihito Nakamori
Second Department of Surgery, Wakayama Medical University, Wakayama, Japan
,
Masahiro Katsuda
Second Department of Surgery, Wakayama Medical University, Wakayama, Japan
,
Keiji Hayata
Second Department of Surgery, Wakayama Medical University, Wakayama, Japan
,
Toshiaki Tsuji
Second Department of Surgery, Wakayama Medical University, Wakayama, Japan
,
Shimpei Maruoka
Second Department of Surgery, Wakayama Medical University, Wakayama, Japan
,
Hiroki Yamaue
Second Department of Surgery, Wakayama Medical University, Wakayama, Japan
› Author Affiliations
TRIAL REGISTRATION: randomized clinical trial UMIN000018486 at http://www.umin.ac.jp
Further Information

Publication History

submitted 14 December 2017

accepted after revision 02 February 2018

Publication Date:
11 September 2018 (online)

Abstract

Background and study aims Interventional endoscopic treatments including the application of glue are becoming more frequently used for the treatment of esophageal fistulas. However, there are no prospective studies of endoscopic treatment for esophageal fistulas. This prospective study aims to investigate the efficacy and safety of endoscopic injection of alpha-cyanoacrylate monomer for intractable esophageal fistulas.

Patients and methods This single-center prospective phase II trial included patients with more than 1 wk of conservative medical treatment for intractable esophageal fistulas after esophagectomy. In the image-guided therapy suite, a mixture of alpha-cyanoacrylate monomer and oily contrast agent in a ratio of 0.3 to 1.7 mL was endoscopically injected through the fistula.

Results Twenty-five patients who underwent esophagectomy at Wakayama Medical University Hospital were enrolled in this study. The primary disease was esophageal cancer in 16 patients (64 %) and gastric cancer in the remaining 9 patients (36 %). Complete closure of the esophageal fistula was performed in 22 patients after endoscopic injection of alpha-cyanoacrylate monomer. The overall success rate was 88 %. There was no fistula recurrence in any successful closure cases. Three patients with failed esophageal fistula closure had esophageal cancer with cervical esophageal fistulas and required reoperation of the fistulectomy under general anesthesia. No complications associated with this endoscopic treatment were detected.

Conclusions Endoscopic treatment with injection of alpha-cyanoacrylate monomer facilitated healing of post-esophagectomy fistula in 88 % of patients without complications. This suggests that the treatment is effective and safe for patients with esophageal fistulas.

 
  • References

  • 1 Kotzampassi K, Eleftheriadis E. Tissue sealants in endoscopic applications for anastomotic leakage during a 25-year period. Surgery 2015; 157: 79-86
  • 2 Dan DT, Gannavarapu B, Lee JG. et al. Removable esophageal stents have poor efficacy for the treatment of refractory benign esophageal strictures (RBES). Dis Esophagus 2014; 27: 511-517
  • 3 Sharma P, Kozarek R. Practice Parameters Committee of American College of Gastroenterology. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol 2010; 105: 258-273
  • 4 Cameron R, Binmoeller KF. Cyanoacrylate applications in the GI tract. Gastrointest Endosc 2013; 77: 846-857
  • 5 Barthelemy C, Audigier JC, Fraisse H. A non-tumoral esophago-bronchial fistula managed by isobutyl-2-cyanoacrylate. Endoscopy 1983; 15: 357-358
  • 6 Yoon JH, Lee HL, Lee OY. et al. Endoscopic treatment of recurrent congenital tracheoesophageal fistula with Histoacryl glue via the esophagus. Gastrointest Endosc 2009; 69: 1394-1396
  • 7 Rotondano G, Viola M, Orsini L. et al. Uncommon cause of early postoperative colonic fistula successfully treated with endoscopic acrylate glue injection. Gastrointest Endosc 2008; 67: 183-186
  • 8 Iwata T, Chung K, Toda M. et al. Malignant esophagobronchial fistula with severe esophageal stenosis, successfully treated by transbronchial occlusion with cyanoacrylate glue. Endoscopy 2012; 44 (Suppl. 02) E317-E318
  • 9 Katada K, Sano H, Katoh Y. et al. Ethyl 2-cyanoacrylate as an embolic agent for cranial arteriovenous malformations. An experimental study. Acta Radiol Suppl 1986; 369: 623-626
  • 10 Willetts IE, Dudley NE, Tam PK. Endoscopic treatment of recurrent tracheo-oesophageal fistulae: long-term results. Pediatr Surg Int 1998; 13: 256-258
  • 11 Billi P, Alberani A, Baroncini D. et al. Management of gastrointestinal fistulas with n-2-butyl-cyanoacrylate. Endoscopy 1998; 30: S69
  • 12 Ojima T, Nakamori M, Nakamura M. et al. Successful treatment of esophageal fistulas with endoscopic injection of alpha-cyanoacrylate monomer. Endoscopy 2014; 46 (Suppl. 01) E62-E63
  • 13 Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213
  • 14 Muto G, D’Urso L, Castelli E. et al. Cyanoacrylic glue: a minimally invasive nonsurgical first line approach for the treatment of some urinary fistulas. J Urol 2005; 174: 2239-2243
  • 15 Groitl H, Horbach T. Endoscopic treatment of anastomosis insufficiency and perforation in the esophagus with fibrin glue. Langenbecks Arch Chir Suppl Kongressbd 1996; 113: 753-754
  • 16 Christophorou D, Valats JC, Funakoshi N. et al. Endoscopic treatment of fistula after sleeve gastrectomy: results of a multicenter retrospective study. Endoscopy 2015; 47: 988-996